Dr. Myung Park, PhD is the President of BiopolyMed, Inc., biotech company that develops PEGylated proteins/peptides to improve the safety, efficacy and dosing characteristics of genes, proteins and peptides. Dr. Park received her PhD from Rutgers University on Protein Chemistry.Coming...
No comments:
Post a Comment